Advance Provision of Mifepristone and Misoprostol via Online Telemedicine in the US

Abigail R A Aiken; Jennifer E Starling; Daniëlle C van Blitterswijk; Carlijn Looijen; Thijs van Vliet; Dirk R Essink; Rebecca Gomperts

doi:10.1001/jamainternmed.2023.7291

Advance Provision of Mifepristone and Misoprostol via Online Telemedicine in the US

JAMA Intern Med. 2024 Feb 1;184(2):220-223. doi: 10.1001/jamainternmed.2023.7291.

Authors

Abigail R A Aiken¹, Jennifer E Starling², Daniëlle C van Blitterswijk³, Carlijn Looijen³, Thijs van Vliet³, Dirk R Essink³, Rebecca Gomperts⁴

Affiliations

¹ LBJ School of Public Affairs, University of Texas at Austin, Austin.
² Mathematica Inc, Cambridge, Massachusetts.
³ Vrije Universiteit, Amsterdam, the Netherlands.
⁴ Aid Access, Amsterdam, the Netherlands.

PMID: 38165689
PMCID: PMC10762629 (available on 2025-01-02)
DOI: 10.1001/jamainternmed.2023.7291

No abstract available

Plain language summary

This cross-sectional study examines trends in the demand and characteristics and motivations of individuals who requested advance provision of abortion medications.

MeSH terms

Abortion, Induced*
Female
Humans
Mifepristone
Misoprostol*
Pregnancy
Telemedicine*

Substances

Mifepristone
Misoprostol